• Explore /
  • Poster
  • / Utility of circulating tumor DNA in monitoring treatment response to immune checkpoint inhibitors in patients with advanced genitourinary cancers.

Utility of circulating tumor DNA in monitoring treatment response to immune checkpoint inhibitors in patients with advanced genitourinary cancers.

Abstract Poster

Authors

Albert Jang

Albert Jang

Tulane University School of Medicine, New Orleans, LA

Albert Jang , Ellen B. Jaeger , Grant Rauterkus , Alexandra Lieberman , Minqi Huang , Sree M Lanka , Sumedha Sudhaman , Tamara Mahmood , Natalia Pajak , Mark Calhoun , Kaoutar Tlemcani , Adam ElNaggar , Minetta Liu , Brian E. Lewis , Jodi Lyn Layton , A. Oliver Sartor , Pedro C. Barata

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 721)

DOI

10.1200/JCO.2023.41.6_suppl.721

Abstract #

721

Poster Bd #

K16

Abstract Disclosures

Similar Posters

First Author: Evangelia Vlachou

First Author: Mario Machado Lopes

First Author: Xiaoting Ma

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Updated pooled analyses of first-line anti-PD1/PD-L1 inhibitors plus chemotherapy in advanced esophageal squamous cell carcinoma.

Updated pooled analyses of first-line anti-PD1/PD-L1 inhibitors plus chemotherapy in advanced esophageal squamous cell carcinoma.

First Author: Maysa Vilbert